מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

METHYLPHENIDATE HYDROCHLORIDE 30 MG

MAH:

MEDILINE LTD.

ATC_code:

N06BA04

pharmaceutical_form:

MODIFIED RELEASE CAPSULES

administration_route:

PER OS

manufactured_by:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

therapeutic_group:

METHYLPHENIDATE

therapeutic_indication:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient.Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

authorization_date:

2011-05-01